SlideShare a Scribd company logo
1 of 64
Jimmy Santana, MBA, P.A. - C

                              1
                  3/13/2009
ο‚— A 24-year-old, white female has recently being diagnosed with insulin-dependent
    diabetes. The disease is being managed on a split dose of 60/40 insulin suspension,
    which she injects herself at 8:00 a.m. and 5:00 p.m. She was told to call in if she
    experiences any strange symptoms, which she does this afternoon. At 2:45 p.m. she
    is not feeling well and notices that her skin is cool and damp. Her hands are
    shaking and she is very anxious. What do you tell her to do right away, before
    having somebody take her to your office?
ο‚—

    A. Inject 4 IU of her insulin
ο‚—
    B. Drink a can of diet soda
ο‚—
    C. Drink six ounces of fruit juice
ο‚—
    D. Eat a large candy bar
ο‚—
    E. Eat a cube of sugar
ο‚— The above described symptoms are classical for hypoglycemia.
  An inexperienced patient needs to be monitored by medical
  personnel until the blood glucose level is stabilized again. The
  first priority though is to prevent the blood sugar to drop any
  further and send the patient into a coma.
ο‚— A six-ounce drink of fruit juice should be sufficient. Since the
  symptoms suggest hypoglycemia, injecting insulin would
  worsen the situation. If in doubt if the patient is hypo- or
  hyperglycemic and there is no possibility for a test, always give
  sugar first and see if the patient improves. An increase of a blood
  glucose level of, for example, 350 is not going to hurt the patient,
  but lowering a level of 45 is going to send the diabetic into a
  coma.
ο‚— Since diet soda contains only sugar substitutes it is not going to
  influence the blood glucose level. A large candy bar could be
  eaten too, but it may raise the glucose level higher than required,
  therefore the fruit juice is a better choice. One cube of sugar is
  an insufficient amount to raise blood sugar; it will take several
  cubes.
ο‚— A 61-year-old white male presents to your office for the first time. In
    reviewing his medical records, you note a history of diabetes type 2
    onset 4 years ago. He is currently well controlled to normal blood
    sugars and hemoglobin A1Cs. You do note that his previous blood
    pressure readings were above normal on multiple visits. In addition to
    his usual diabetic care, you recommend initiation of drug therapy for
    his hypertension. Your drug of choice is


ο‚— A. Calcium channel blocker
ο‚—
    B. ACE inhibitor
ο‚—
    C. Alpha blocker
ο‚—
    D. Thiazide diuretic
ο‚—
    E. Beta blocker
ο‚— ACE inhibitors have been shown to slow the progress
 of proteinuria in patients with diabetes. Control of
 their blood pressure is just as important. Your drug of
 choice should be an ACE inhibitor for any diabetic
 with hypertension as long as there are no
 contraindications to giving them this medicine.
A 55-year-old male is brought into the urgent care center of your hospital by paramedics. He is
3.
     obtunded, and today his wife could not get him out of bed. He has no significant past medical history. His
     wife states that he has not been well for the last week, with decreased energy and fatigue. In addition, he
     has had a productive cough, which has worsened during the last 3 days. Also, according to his wife, he
     appears to be drinking more water. Physical exam reveals a lethargic male who moves to deep pain but
     has no intelligible speech. Paramedics have given the patient Narcan with no change in his status but
     have withheld glucose bolus due to a high dextro stick reading. Vital signs are pulse 115; BP 90/50;
     respiration 18; Temp 38.2Β° C (100.7Β° F)
     HEENT shows dry mucous membranes. Lungs are clear. Cardiac exam is significant for tachycardia.
ο‚—
     Abdominal exam is nonspecific. Neurologic exam shows the patient to be responsive only to pain, with
     withdrawal. No abnormal reflexes noted.
     Initial laboratory studies show: Na 118; K 4.2; Cl 97; HCO3 21; Glucose 1050. ABG reveals pH 7.34, pCO2
ο‚—
     20; pO2 79; O2 saturation 90%. CBC shows a normal H/H with WBC count of 14K; the serum is reported
     as very lipemic. Chest X-ray shows an LLL consolidation. The most likely cause for the change in the
     patient's mental status is


     A. Acute diabetic ketoacidosis
ο‚—


     B. Pseudohyponatremia
ο‚—

     C. Pneumococcal pneumonia with hypoxia
ο‚—

     D. Hyperglycemic hyperosmolar nonketotic coma
ο‚—

     E. Central pontine myelinolysis
ο‚—
ο‚— Hyperglycemic hyperosmolar nonketotic coma (HHNC) represents a
    syndrome characterized by marked hyperglycemia, hyperosmolarity, and
    dehydration. It is manifested by decreased mental functioning that may
    progress to frank coma. Ketosis and acidosis are generally minimal.
    DKA, acute diabetic ketoacidosis, will have similar electrolyte
ο‚—
    abnormalities; however, there will be an associated metabolic acidosis and
    ketosis.
    The patient does show pseudohyponatremia, which is due to the presence
ο‚—
    of hyperglycemia and hyperlipidemia. In the absence of marked lipemia,
    the true value for sodium can be approximated by adding 1.3 to 1.6 mEq/L
    to the sodium value for every 100 mg/dl glucose over the norm. But this is
    not the cause of this patient's altered sensorium.
    The patient most likely has pneumococcal pneumonia, which is a
ο‚—
    common precipitating factor in the development of HHNC. He is mildly
    hypoxic, though this does not explain the degree of obtundation seen.
    Overly aggressive restoration of serum sodium levels in hyponatremic
ο‚—
    patients can be associated with central pontine myelinolysis and
    circulatory overload.
ο‚— A 28-year-old type I diabetic on multiple daily insulin injections regimen
  presents to your office for a follow up visit. She complained to you about her
  early morning glucose level during her last visit and you recommended for
  her to chart the numbers and bring it for her next appointment. Her pre-
  breakfast glucose averaged 285mg/dL; dinnertime was 95mg/dL and
  68mg/dL at 3 AM. How will you treat her diabetes?


ο‚— A. Increase the evening dose of long acting insulin

ο‚— B. Decrease the evening dose of long acting insulin

ο‚— C. Decrease the evening dose of short acting insulin

ο‚— D. Increase the evening dose of short acting insulin

ο‚— E. Increased activity before bedtime
ο‚— Three mechanisms can account for early morning hyperglycemia in
    patients with diabetes on insulin:
1. Inadequate dose of long acting insulin at night
2. Somogyi effect or rebound hyperglycemia is a condition often seen in
    type I diabetes, in which there is nocturnal hypoglycemia. The
    hypoglycemia subsequently stimulates the release of counter regulatory
    hormones leading to increase of glucose level in the blood. Diagnosis
    can be made by several plasma glucose analyses done at 2.00 A.M, 3.00
    A.M, and 7.00A.M.
3. In the dawn phenomenon, the hyperglycemia is secondary to increased
    need for insulin in the early morning due to the normal early morning
    surge of growth hormone, which antagonizes insulin action.
ο‚— Checking the blood glucose level at 3 AM can help differentiate
    between Somogyi effect and dawn phenomenon: the level will be low
    in Somogyi phenomenon. The patient's early morning hyperglycemia is
    due to Somogyi effect since her 3 AM level was low. Treatment of this
    will be to decrease the evening dose of long-acting insulin or give
    bedtime snacks. The treatment of dawn phenomenon involves
    increasing the evening dose of long-acting insulin.
ο‚— There is no nocturnal hypoglycemia if the night dose of insulin is
    inadequate.
A 62-year-old male with a history of diabetes for twenty-five years and hypertension for
ο‚—
    ten years is referred to your office by a retired physician. He complains of worsening
    edema on the right lower extremity during the last two weeks. Vital signs show T 97.8
    Pulse 78 RR 20 BP 165/93. Physical examination disclosed periorbital edema and left
    lower extremity edema 1+ below the knee and right lower extremity edema 3+ below the
    knee that is nontender to palpation. He denies any fever, chills, or malaise. He is
    currently on glipizide 20 mg twice a day and amlodipine 10-mg once daily. Laboratory
    result from two weeks ago shows Na 145, K 4.5, Cl 102, HCO3 25, BUN 14, Creat 1.2, CA
    7.2, Glucose 287, HgA1C 8.6, and Albumin 2.5. The U/A test shows 3+ proteins with no
    WBC or RBC.
    Question: What is the most appropriate next step in management of his diabetes?


    A. Start the patient on glyburide
ο‚—

    B. Start the patient on insulin therapy
ο‚—

    C. There is no indication to change his diabetes therapy. His HgA1C shows that his
ο‚—
    diabetes is under control

    D. Start the patient on metformin
ο‚—

    E. Repeat the patient's HgbA1C; result is too old to reflect the current HgbA1C level
ο‚—
ο‚— This patient's diabetes mellitus is poorly managed. Glycosylated
  hemoglobin (HbA1c) is the best indicator of glycemic control
  over the previous 3 months. Maintaining an HgA1C of 7 or less
  lowers the rate of complications of diabetes mellitus. Adding a
  second class of oral hypoglycemic agent would be the next best
  choice. Metformin is the drug from the biguanides class;
  therefore, it is the drug of choice.
ο‚— Starting the patient on glyburide is incorrect because both
  glyburide and glipizide belong to the sulfonylurea class. Starting
  the patient on insulin therapy is incorrect because oral therapy
  should be maximized before starting on insulin. HgA1c of 8.6
  indicates poorly controlled diabetes. There is a need to change
  his diabetes management. There is no need to repeat HgA1C.
  Glycosylated hemoglobin (HbA1C) is the best indicator of
  glycemic control over the previous 3 months. The result is not
  too old.
ο‚— A 38-year-old obese female with type 2 diabetes mellitus presents to your office
  for follow up visit. Her blood sugar has been well controlled on metformin. She
  wants to have a baby and wants to know if there is any special thing to do so
  that her diabetes will not affect her pregnancy. Which of the following is
  appropriate for her?


ο‚— A. Switch her to insulin

ο‚— B. Switch to glyburide

ο‚— C. Tell her it is not advisable for her to be pregnant because her child will be
  diabetic

ο‚— D. Increase the dose of her metformin to prevent worsening of her blood sugar
  during pregnancy

ο‚— E. Continue her present treatment and dose
ο‚— Diabetic patients that are pregnant or attempting to
 get pregnant, irrespective of whether they are insulin
 requiring or not, should be switched to insulin
 therapy for their glucose control. Oral glucose
 lowering agents are contraindicated in pregnancy.
 Although a poor glucose control predisposes to
 increased maternal and fetal risks, it is not a
 contraindication to pregnancy. A good glucose control
 is however necessary prior to and during pregnancy.
ο‚— A 24-year old white male present to the flight
  physician assistant’s office for a routine physical. He
  has been taking flying lessons and is applying for a
  pilot’s license. Regulations state that he must have a
  physical examination.
ο‚— Examination discloses a thin male, 74 inches, 140
  pounds. Generally, the exam is unremarkable. Routine
  screening includes a urinalysis, which demonstrates
  4+ glycouria.


                                                       16
                                   3/13/2009
There is insufficient information to establish a diagnosis.
ο‚—
    There are other reasons to spill glucose in the urine. You
    must ask additional questions.
    You find out that even though he denies any history of
ο‚—
    diabetes, he admits to:
            Having incessant thirst
       1.
            Increase hunger
       2.
            Increase urination
       3.
            He has lost 15 pounds over the last three months
       4.




                                                                  17
                                                3/13/2009
ο‚— A glucometer reading revealed a glucose of 490 mg/dl
ο‚— A blood glucose revealed a glucose level of 496 mg/dl.
  With normal electrolytes and anion gap
ο‚— Does this patient have diabetes?




                                                           18
                                     3/13/2009
ο‚— Three ways to diagnose diabetes mellitus:
  ο‚— Fasting glucose of > 126 mg/dl
  ο‚— Oral glucose tolerance test with a 2 hr value
    of > 200 and one other value in-between of
    > 200
  ο‚— Grossly elevated serum glucose with classic
    signs and




                                                  19
                           3/13/2009
ο‚— New onset Type I diabetics should be
 admitted because:
  ο‚— He needs to start on insulin
  ο‚— He requires a lot of patient education




                                             20
                            3/13/2009
ο‚— 32-year old woman who has type I diabetes calls
  you over the weekend. She has been having some
  nausea and vomiting for the last 24 hours and can
  not keep solids down. She has been able to keep
  liquids down. Her last glucometer reading was
  261 mg/dl.
ο‚— She is on a split dose of NPH and regular insulin
  twice daily. She did not take her morning insulin
  because a physician had told her never to take her
  insulin when she is not eating. She ask you for
  instructions?

                                                    21
                               3/13/2009
ο‚— Many patients do not take their insulin if they
 are not eating; this is wrong.
  ο‚— It is important for IDDM patients and their
    providers to learn how to manage β€œsick days”.
  ο‚— Note that one of the most common reasons for
    patient to go into DKA is poor management of
    their diabetes when they are sick.
  ο‚— Insulin should be taken regardless of whether or
    not they are eating
  ο‚— Adequate carbohyrates should be taken (15 –
    20g q2h)




                                                    22
                             3/13/2009
ο‚— The patient can consume regular coke, Sprite,
    juices @ 4 – 6 oz q2hrs.
    They can also have gelatin, crackers, soup
ο‚—
    Patients that are sick require more insulin
ο‚—
    NOT less
    The intermediate or long acting insulin should
ο‚—
    be given
    Regular insulin should be given q4h as per a
ο‚—
    β€˜sliding scale’




                                                23
                             3/13/2009
ο‚— 69-year old white female was in good
 health until 3 weeks ago, when she
 suddenly developed severe polyuria,
 polydipsia and polyphagia. She has lost 20
 pounds ( going from 120 to 100) during
 that period and feels extremely weak.
 When her daughter brings her to you, in
 the ED, she is somewhat lethargic. Past
 medical history reveals HTN(Tx with a
 small dose of enalapril). There is no
 history of cardiac disease.

                                         24
                       3/13/2009
ο‚— Physical Exam reveals a pale, lethargic,
  confused woman, breathing rapidly.
ο‚— B/P is 102/72 P 110 Resp 32
ο‚— Her skin is very dry, bowel sounds are weakly
  positive
ο‚— Blood test revealed
      Na+ 130 (135 – 145)
  ο‚—
      K+ 5.1 (3.5 – 5.1)
  ο‚—
      Glucose 794 ( 70 – 110)
  ο‚—
      Cl- 104 (95 – 105)
  ο‚—
      HCO3 3mEq/L (21 – 30)
  ο‚—
      pH 6.92 (7.35 – 7.45)
  ο‚—
      pO2 92 mm (80 – 105)
  ο‚—



                                                  25
                                3/13/2009
ο‚— A 37 year old white female has a 20 year
  history of diabetes mellitus. She has
  been having difficulty with
  hypoglycemia in the early morning. She
  used to be on beef-pork insulin and did
  not have any problems.
ο‚— She takes:
  ο‚— Human NPH 16U am; 8 U pm
  ο‚— Human Regular 8 U am; 3 U pm




                                         26
                     3/13/2009
ο‚— Blood glucose monitoring reveal:
3am         7am          12pm        5pm
41          66           109         72
47          132          82          100
35          182          134         142

ο‚— Why is she developing early-morning
 hypoglycemia?

                                           27
                         3/13/2009
ο‚— Insulin have different peaks and duration of
  action.
ο‚— In this case you must note that animal insulin has
  a slower peak than human insulin
ο‚— In this case this lady was advised to move the
  NPH evening dose to qhs --- which allowed the
  NPH peak to occur later
ο‚— To cover the evening problem one should also
  increase the bedtime regular insulin --- in this
  case it was increased by 2 U



                                                  28
                             3/13/2009
ο‚— A 56-year male has a history of type II diabetes for 10
  years. He is currently on glipizde 20 mg BID and
  monitors his glucose twice a day. Over the last 2 weeks
  his fasting glucose were 157 – 278 (average 199); supper
  values were 145 – 292 (average 212).




                                                             29
                                       3/13/2009
ο‚— Yesterday his fasting glucose was 234 and
  HgA1c was 14.8%
ο‚— P.E.: B/P 142/90 P 72 Resp. 12 height:72 inches
  weight: 212
ο‚— The rest of the physical was normal with no
  evidence of retinopathy or neuropathy

ο‚— What is the best option for this patient?




                                                30
                             3/13/2009
ο‚— Though this patient may not want to go
 on insulin …. We have no choice.
  ο‚— He has unacceptably high glucose
    values
  ο‚— HgA1C confirms the fact that insulin is
    needed

  ο‚— What do we start him on?




                                              31
                      3/13/2009
ο‚— Many clinicians start their type II that now
  require insulin on NPH or ultralente and add
  regular insulin later as needed to tune – up
  treatment.
ο‚— After knowing what it would take to treat this
  patient --- you may then decide to use pre-
  mixed insulin.

ο‚— Should this patient be hospitalized?
  ο‚— No




                                                 32
                            3/13/2009
ο‚— A 30-year female has no prior medical
  problems. As part of a routine obstetric
  care, she has a glucose screen at 24 weeks.
  She is given 50-g glucose to drink and a
  glucose level is obtained 1 hour later. Her
  results revealed a level of 156 mg (<140)
ο‚— She is 64 inches tall and weighs 220
ο‚— What do you do know?




                                                33
                          3/13/2009
ο‚— You should now order a 3 hr GTT,
  which they give 100 g of glucose
ο‚— Her results were
  ο‚— Fasting: 112mg
  ο‚— 1hour:     183mg
  ο‚— 2hour:   172mg
  ο‚— 3hour:   147mg
ο‚— What is your opinion?




                                     34
                       3/13/2009
ο‚— This patient has Gestational Diabetes. According to
  the National Diabetes Data Group – Dx is made if two
  or more values exceed the norm.
ο‚— You should start this patient on a ADA 2000 calorie
  diet, give her a glucometer(she to take readings four
  times daily) and see her in a week.




                                                          35
                                     3/13/2009
ο‚— You see her back in a week and her glucose log reveal:
Fasting      LunchSupper      Bedtime
97            93        115         104
112          101         107         99
101          101         89          122
93            105        102          111
115           112         121         118
99             107        113         105
96              101       117         109



                                                           36
                                     3/13/2009
ο‚— What should you do now?


ο‚— This patient should be started on insulin.
  Though these level appear good; in pregnancy
  glucose levels are significantly lower.
ο‚— Target glucose goals are:
      Fasting: 60 – 90
  ο‚—
      Non-fasting (before breakfast) 60 – 105
  ο‚—
      After meals: < 120
  ο‚—
      2am – 6am: >60
  ο‚—




                                                 37
                                 3/13/2009
ο‚— Since most of these patients seem to be insulin
  resistant it is recommended to start with
  0.6U/kg/day. In this patient we would give 30 –
  32 U NPH (or Longer acting) BID. She returns
  in four days with the following readings:
Fasting        LunchSupper       Bedtime
93              99           97         122
86             100           98          113
74             78            99          107
68             90            79          112



                                                38
                             3/13/2009
ο‚— How is our patient doing?
ο‚— These reading show that we still have a problem at
 bedtime. Therefore, we should add 2U of regular
 insulin in the evenings




                                                       39
                                     3/13/2009
40
3/13/2009
A 58 year-old man with a 12 year history of type 2 diabetes comes to
    your office because of an ulcer in his right foot. Physical exam
    reveals a 1-cm irregular ulceration over the right metatarsal
    head, surrounded by an area of black gangrenous skin. The
    patient is admitted and undergoes amputation of the right
    forefoot. Which of the following would have been most
    effective in preventing this complication?

   Appropriate instructions on self-care of the feet
A.
B. Doppler exam of the lower extremities
C. Nuerophysiologic and electromyographic studies
D. Local application of platelet-derived growth factor
E. Prophylactic treatment with cholesterol-lowering agents



                                                                   41
Screening
1.
     Current guidelines
2.
     Use of oral agents
3.
     Insulin regimens
4.
     Gestational diabetes
5.




                            42
45 years old; repeat q 3 years
ο‚—
    Overweight (BMI 25 kg/m2*)
ο‚—
    Physically inactive
ο‚—
    Have a first-degree relative with diabetes
ο‚—
    High-risk ethnic population
ο‚—
    h/o GDM or baby >9 lbs
ο‚—
    HTN
ο‚—
    Hyperlipidemia
ο‚—
    PCOS
ο‚—
    Other sx of insulin resistance (acanthosis)
ο‚—
    h/o vascular disease
ο‚—


                                                  43
Symptoms of diabetes and a casual plasma glucose 200 mg/dl or..
1.
     FPG 126 mg/dl ( no caloric intake for at least 8 hr) or…
2.
     BS 200 mg/dl after OGTT (2 hr after 75 gm glucose).
3.

     In the absence of unequivocal hyperglycemia, these
ο‚—
criteria should be confirmed by repeat testing on a different
day.

    OGTT is not recommended for routine clinical
ο‚—
use, but may be required in the evaluation of patients with
IFG or when diabetes is still suspected despite a
normal FPG as with the postpartum evaluation of women
with GDM.


                                                                       44
A1C<7.0% (q 3 mo if uncontrolled; twice yr if at goal)
ο‚—
    Preprandial BS 80-110 mg/dl (60-90 if pregnant)
ο‚—
    Postprandial BS<140 mg/dl (<120 if pregnant)
ο‚—
    Blood pressure<130/80 mmHg
ο‚—
    LDL<100 mg/dl
ο‚—
    Triglycerides <150 mg/dl
ο‚—
    HDL>40 mg/dl
ο‚—
    Annual influenza vaccine
ο‚—
    Pneumococcal vaccine for adults with diabetes
ο‚—
    Revaccination is for individuals >64 if vaccine was
ο‚—
    administered >5 years ago. Other indications for repeat
    vaccination include nephrotic syndrome, chronic renal
    disease, and other immunocompromised states, such as
    after transplantation.


                                                              45
ο‚— SMBG TID w/ DM1 and GDM
ο‚— BP each visit
ο‚— Annual urinary microalbumin (<30ug/mg)
ο‚— Annual lipids
ο‚— Annual optho exam starting 3-5 yrs after onset w/
  DM1, and upon diagnosis in DM 2
ο‚— Visual foot exam each visit. Comprehensive exam
  yearly (sensation, biomechanics, foot structure,
  vascular status and skin integrity)

                                                      46
47
ο‚— Risk assessment at first prenatal visit
ο‚— Low-risk status requires no glucose testing
οƒ˜ Age <25 years
οƒ˜ Weight normal before pregnancy
οƒ˜ Member of an ethnic group with low prevalence
οƒ˜ No known diabetes in first-degree relatives
οƒ˜ No history of abnormal glucose tolerance
οƒ˜ No history of poor obstetric outcome


ο‚— High risk features (obesity, h/o GDM, glycosuria,
 or FH) should undergo glucose testing as soon as
 possible
                                                      48
ο‚— FPG 126 mg/dl or a casual plasma glucose 200 mg/dl meets the threshold
  for the diagnosis of diabetes (confirm on subsequent day)
ο‚— High-risk women not found to have GDM at initial screening and average-
  risk women should be tested between 24 and 28 weeks of gestation.
  Testing should follow one of two approaches:

  One-step approach: 100-g OGTT
ο‚—
οƒ˜ 95 mg/dl fasting
οƒ˜ 180 mg/dl at 1 h
οƒ˜ 155 mg/dl at 2 h and 140 mg/dl at 3 h.
*Two or more of the plasma glucose values must be met or exceeded for a
  positive diagnosis

ο‚— Two-step approach: perform an initial screening by measuring the plasma
    or serum glucose concentration 1 h after a 50-g oral glucose load and
    perform a diagnostic 100-g OGTT on that subset of women exceeding 140
    mg/dl

                                                                          49
Drug Class                     Mechanism of Action       Side Effects

                               ↑insulin secretion
Sulfonylureas/ secretagogues                             weight gain, hypoglycemia

                               ↓hepatic glucose output
Metformin                                                GI upset, lactic acidosis,


TZD’s                          ↑ peripheral glucose      fluid retention, weight gain
                                   disposal
                               ↓ intestinal
Alpha-glucosidase inhibitors                             flatulence, diarrhea
                                   carbohydrate
                                   absorption


 *Each will lower A1c by 1-2% compared to
 placebo. When combined, efficacy typically
 is additive
                                                                                        50
Sulfonylurea   +   Metformin
Sulfonylurea   +   Ξ±-glucosidase inhibitors
Sulfonylurea   +   TZD
Metformin      +   Secretagogues
Metformin      +   TZD
Insulin        +   Sulfonylurea
Insulin        +   Metformin
Insulin        +   TZD




                                              51
ο‚— Know the types of insulin and onset
ο‚— Know how to adjust insulin
ο‚— All regimens include basal and bolus




                                         52
β€’Make changes slowly, taking into account diet, activity,
stress

β€’Asses the effectiveness of insulin at its peak time of
action

β€’Increase short/rapid insulin based on post-prandial
readings

β€’Increase long-acting when BG high fasting or
throughout day

β€’Inject into subcutaneous abdomen and rotate sites
                                                            53
ο‚— To ↓ pre-dinner BG…….↑AM intermediate-acting (e.g.,
 NPH)

ο‚— To ↓ fasting BG……….. ↑PM long/intermediate-acting
 insulin (e.g., glargine, NPH)

ο‚— To ↓ pre-lunch BG……..↑AM short/rapid-acting insulin
 (e.g., regular, lispro, aspart)

ο‚— To ↓ bedtime BG…...….↑PM short/rapid-acting insulin
 (regular, lispro, aspart)

                                                        54
                                   3/13/2009
ο‚— Onset within 24 hours
ο‚— Diabetic ketoacidosis DKA
  ο‚— usually seen with Type 1
  ο‚— Liver cannot metabolize and kidneys cannot excrete
  ο‚— Hyperglycemia (>250)
  ο‚— Ketosis (positive urine dipstick)
  ο‚— Metabolic acidosis (HCO3 < 15; pH <7.3)
  ο‚— May mimic β€œflu” Polyuria, polydipsia, nausea,
    vomiting, abdominal pain, breath smells like booze.
Decreased insulin, high counterregulatory hormones
    (catecholamines, glucagon, GH, cortisol), leading to
    hyperglycemia, proteolysis, lipolysis & ketone production

    Diagnostic Criteria
    hyperglycemia: glucose>250 mg/dl
ο‚—
    acidosis: pH <7.35; HCO3 < 18
ο‚—
    ketosis (blood &/or urine)
ο‚—

    Therapeutic Goals
    Improve circulating volume & tissue perfusion
ο‚—
    Identify precipitating factors
ο‚—
    FLUIDS restores intravascular volume, decreases
ο‚—
    counterregulatory hormones and lowers glucose levels
    Reduce Gluc. & serum osmolarity: lytes q2, glucose q1
ο‚—
    Clear ketones, fix electrolytes
ο‚—

                                                                56
ο‚— HHNK - Hyperglycemic, hyperosmolar, non-
 ketotic coma. Onset 2 days to 2 weeks.
  ο‚— Osmolarity > 310
  ο‚— Glucose > 600
  ο‚— Usually seen with Type 2
     ο‚— exhibiting increasing insulin resistance, esp. after gorging
       on CHO.
  ο‚— Presents with marked dehydration and CNS SSx
    often mimicking a stroke.
  ο‚— Must correct S-L-O-W-L-Y to prevent cerebral
    edema. Watch K+ levels.
ο‚— Hypoglycemia
  ο‚— Glucose < 50
  ο‚— Causes:
     ο‚— Not enough to eat (or forgot)
     ο‚— Too much insulin (or pills)
     ο‚— Did not allow for exercise
  ο‚— CNS- confusion, delirium, coma
  ο‚— Autonomic - hunger, anxiety, SWEATING, tachycardia.
  ο‚— If patient is conscious - give OJ. Otherwise injection of
    glucagon, glucose gel in mouth, or 50% glucose by IV
    push.
ο‚— Neuropathies - peripheral
  ο‚— Obstruction of vessels that supply nerves
  ο‚— Demyelination
  ο‚— Sensory
     ο‚— Paresthesias
     ο‚— Decreased sensitivity to pain, temperature and light
       touch.
     ο‚— Decreased proprioception and vibration sense.
  ο‚— Motor
     ο‚— Weakness
     ο‚— Atrophy
ο‚— Neuropathies - central and autonomic
  ο‚— orthostatic hypotension
  ο‚— gastrointestinal atony
  ο‚— atonic urinary bladder
  ο‚— impotence
  ο‚— impairment of special senses
ο‚— Nephropathy
      Glomerulosclerosis (arteriolonephrosclerosis)
  ο‚—
      Thickened basement membrane in glomerulus
  ο‚—
      Causes microalbuminuria (300 mg / day)
  ο‚—
      Nodular scarring and destruction of glomerulus.
  ο‚—
      Kimmelstiel - Wilson lesion. Pathognomonic for
      diabetes mellitus.
ο‚— Retinopathy
ο‚— Leading cause of blindness. DM has increased risk
  for cataracts and glaucoma
ο‚— Pathogenesis:
  ο‚— new vessels, fragile vessels, microaneurysms,
    hemorrhage. Followed by scarring and retinal
    detachment. Takes 20 years to develop. 100% of
    Type 1; 60% Type 2. Need to evaluate yearly.
    Retinal photos excellent.
ο‚— Foot ulcers
  ο‚— Most common reason for hospitalization
  ο‚— Due to impaired circulation (PVD)
     ο‚— Abnormal glycoprotein thickens vessel wall
     ο‚— Chronic hypoxia (glycohgb has > affinity for O2)
  ο‚— Due to neuropathy
     ο‚— Cannot feel pain to prevent injury
  ο‚— Prevention: Wear good closed-toe shoes, white
    cotton socks, keep feet clean and dry, clip toenails
    straight across, inspect feet daily.
ο‚— Infections
  ο‚— Skin: boils and abscesses
  ο‚— Urinary tract infections - quickly spread to kidneys
  ο‚— Osteomyelitis
  ο‚— Infected cuts of extremities
  ο‚— Peridontal disease
  ο‚— Finger and toenail fungus

More Related Content

What's hot

Diabetes Remission and Prevention
Diabetes Remission and PreventionDiabetes Remission and Prevention
Diabetes Remission and PreventionUsama Ragab
Β 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitusSaran Adgiri
Β 
Type 1 Diabetes Mellitus
Type 1 Diabetes MellitusType 1 Diabetes Mellitus
Type 1 Diabetes MellitusJaymax13
Β 
Educational Grand Rounds: Diabetes and Lifestyle Modification
Educational Grand Rounds: Diabetes and Lifestyle ModificationEducational Grand Rounds: Diabetes and Lifestyle Modification
Educational Grand Rounds: Diabetes and Lifestyle ModificationS'eclairer
Β 
Insulin therapy in type 2 diabetes
Insulin therapy in type 2 diabetesInsulin therapy in type 2 diabetes
Insulin therapy in type 2 diabetesMohsen Eledrisi
Β 
DIABETES MELLITUS TYPE 1 & MANAGEMENT OF DIABETIC KETOACIDOSIS
DIABETES MELLITUS TYPE 1 & MANAGEMENT OF DIABETIC  KETOACIDOSIS DIABETES MELLITUS TYPE 1 & MANAGEMENT OF DIABETIC  KETOACIDOSIS
DIABETES MELLITUS TYPE 1 & MANAGEMENT OF DIABETIC KETOACIDOSIS Rakesh Verma
Β 
Diabetes in young
Diabetes in young Diabetes in young
Diabetes in young ikramdr01
Β 
Diabetes Mellitus Types Diet Maintenance and Exercise
Diabetes Mellitus Types  Diet Maintenance and ExerciseDiabetes Mellitus Types  Diet Maintenance and Exercise
Diabetes Mellitus Types Diet Maintenance and Exerciseshama shabbir
Β 
Diabetes Mellitus- Case Presentaion by Jayesh Anil Mahirrao
Diabetes Mellitus- Case Presentaion by Jayesh Anil MahirraoDiabetes Mellitus- Case Presentaion by Jayesh Anil Mahirrao
Diabetes Mellitus- Case Presentaion by Jayesh Anil MahirraoJayesh Mahirrao
Β 
Ramadan and diabetes
Ramadan and diabetesRamadan and diabetes
Ramadan and diabetespromotemedical
Β 
Case Study Type 1 Diabetes
Case Study Type 1 DiabetesCase Study Type 1 Diabetes
Case Study Type 1 DiabetesYeyan Jin
Β 
Diabetes case study(2)
Diabetes case study(2)Diabetes case study(2)
Diabetes case study(2)terafischer
Β 

What's hot (20)

Diabetes Remission and Prevention
Diabetes Remission and PreventionDiabetes Remission and Prevention
Diabetes Remission and Prevention
Β 
Premixed insulin dosing in actual practice
Premixed insulin dosing in actual practicePremixed insulin dosing in actual practice
Premixed insulin dosing in actual practice
Β 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
Β 
Type 1 Diabetes Mellitus
Type 1 Diabetes MellitusType 1 Diabetes Mellitus
Type 1 Diabetes Mellitus
Β 
Educational Grand Rounds: Diabetes and Lifestyle Modification
Educational Grand Rounds: Diabetes and Lifestyle ModificationEducational Grand Rounds: Diabetes and Lifestyle Modification
Educational Grand Rounds: Diabetes and Lifestyle Modification
Β 
Insulin therapy in type 2 diabetes
Insulin therapy in type 2 diabetesInsulin therapy in type 2 diabetes
Insulin therapy in type 2 diabetes
Β 
DIABETES MELLITUS TYPE 1 & MANAGEMENT OF DIABETIC KETOACIDOSIS
DIABETES MELLITUS TYPE 1 & MANAGEMENT OF DIABETIC  KETOACIDOSIS DIABETES MELLITUS TYPE 1 & MANAGEMENT OF DIABETIC  KETOACIDOSIS
DIABETES MELLITUS TYPE 1 & MANAGEMENT OF DIABETIC KETOACIDOSIS
Β 
Diabetes in young
Diabetes in young Diabetes in young
Diabetes in young
Β 
Diabetes mellitus by dr shahjada selim
Diabetes mellitus by dr shahjada selimDiabetes mellitus by dr shahjada selim
Diabetes mellitus by dr shahjada selim
Β 
Diabetes Mellitus Types Diet Maintenance and Exercise
Diabetes Mellitus Types  Diet Maintenance and ExerciseDiabetes Mellitus Types  Diet Maintenance and Exercise
Diabetes Mellitus Types Diet Maintenance and Exercise
Β 
Diabetes Mellitus- Case Presentaion by Jayesh Anil Mahirrao
Diabetes Mellitus- Case Presentaion by Jayesh Anil MahirraoDiabetes Mellitus- Case Presentaion by Jayesh Anil Mahirrao
Diabetes Mellitus- Case Presentaion by Jayesh Anil Mahirrao
Β 
Insulin initiation adjustment
Insulin initiation adjustmentInsulin initiation adjustment
Insulin initiation adjustment
Β 
ADA GUIDELINE.pptx
ADA GUIDELINE.pptxADA GUIDELINE.pptx
ADA GUIDELINE.pptx
Β 
Ramadan and diabetes
Ramadan and diabetesRamadan and diabetes
Ramadan and diabetes
Β 
Early Detection and Management of Diabetes by Dr Shahjada Selim
Early Detection and Management of Diabetes by Dr Shahjada SelimEarly Detection and Management of Diabetes by Dr Shahjada Selim
Early Detection and Management of Diabetes by Dr Shahjada Selim
Β 
Diabetes
Diabetes Diabetes
Diabetes
Β 
Case Study Type 1 Diabetes
Case Study Type 1 DiabetesCase Study Type 1 Diabetes
Case Study Type 1 Diabetes
Β 
Insulin regimens
Insulin regimensInsulin regimens
Insulin regimens
Β 
Diabetes case study(2)
Diabetes case study(2)Diabetes case study(2)
Diabetes case study(2)
Β 
Diabetes case-study
Diabetes case-studyDiabetes case-study
Diabetes case-study
Β 

Viewers also liked

Diabetes Mellitus: Presentation and CLinical Examination
Diabetes Mellitus: Presentation and CLinical ExaminationDiabetes Mellitus: Presentation and CLinical Examination
Diabetes Mellitus: Presentation and CLinical ExaminationPranab Chatterjee
Β 
Patient Case Presentation
Patient Case PresentationPatient Case Presentation
Patient Case PresentationJennifer Heasley
Β 
Diabetes Mellitus
Diabetes MellitusDiabetes Mellitus
Diabetes MellitusKhalid
Β 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitusSara Ravi
Β 
Cardiology cases ppt 4slideshare
Cardiology cases ppt 4slideshareCardiology cases ppt 4slideshare
Cardiology cases ppt 4slidesharehospital
Β 
Case Report: Prostate Cancer/Septic Shock
Case Report: Prostate Cancer/Septic ShockCase Report: Prostate Cancer/Septic Shock
Case Report: Prostate Cancer/Septic ShockJohn R. Martinelli, MD, OD
Β 
ECTODERMAL DYSPLASIA
ECTODERMAL DYSPLASIAECTODERMAL DYSPLASIA
ECTODERMAL DYSPLASIADr Yugandar
Β 
A case presentation on viral pneumonia
A case presentation on viral pneumoniaA case presentation on viral pneumonia
A case presentation on viral pneumoniaSaraswati Roy
Β 
PTERYGOID HAMULUS SYNDROME- A CASE REPORT
PTERYGOID HAMULUS SYNDROME- A CASE REPORTPTERYGOID HAMULUS SYNDROME- A CASE REPORT
PTERYGOID HAMULUS SYNDROME- A CASE REPORTShuddhodhan Gaikwad
Β 
Gestational diabetes case study 2nd one
Gestational diabetes case study 2nd oneGestational diabetes case study 2nd one
Gestational diabetes case study 2nd oneLisette Allender
Β 
Diagnostic records /certified fixed orthodontic courses by Indian dental acad...
Diagnostic records /certified fixed orthodontic courses by Indian dental acad...Diagnostic records /certified fixed orthodontic courses by Indian dental acad...
Diagnostic records /certified fixed orthodontic courses by Indian dental acad...Indian dental academy
Β 
Case Report: Heparin Induced Thrombocytopenia (HIT)
Case Report: Heparin Induced Thrombocytopenia (HIT)Case Report: Heparin Induced Thrombocytopenia (HIT)
Case Report: Heparin Induced Thrombocytopenia (HIT)John R. Martinelli, MD, OD
Β 
Ptosis case report
Ptosis case reportPtosis case report
Ptosis case reportsameep94
Β 
Cardiology case report...an example
Cardiology case report...an exampleCardiology case report...an example
Cardiology case report...an exampleDipayan Banerjee
Β 
Renal Tumour Angiomyolipoma - Bizarre Presentation
Renal Tumour Angiomyolipoma - Bizarre PresentationRenal Tumour Angiomyolipoma - Bizarre Presentation
Renal Tumour Angiomyolipoma - Bizarre PresentationSanjoy Sanyal
Β 
Ectodermal Dysplasia: a case report and overview
Ectodermal Dysplasia: a case report and overview Ectodermal Dysplasia: a case report and overview
Ectodermal Dysplasia: a case report and overview Waikhom Singh
Β 

Viewers also liked (20)

Diabetes Mellitus: Presentation and CLinical Examination
Diabetes Mellitus: Presentation and CLinical ExaminationDiabetes Mellitus: Presentation and CLinical Examination
Diabetes Mellitus: Presentation and CLinical Examination
Β 
Patient Case Presentation
Patient Case PresentationPatient Case Presentation
Patient Case Presentation
Β 
Clinical cases of type 2 diabetics
Clinical cases of type 2 diabeticsClinical cases of type 2 diabetics
Clinical cases of type 2 diabetics
Β 
Diabetes Mellitus
Diabetes MellitusDiabetes Mellitus
Diabetes Mellitus
Β 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
Β 
Lung cancer
Lung cancerLung cancer
Lung cancer
Β 
Cardiology cases ppt 4slideshare
Cardiology cases ppt 4slideshareCardiology cases ppt 4slideshare
Cardiology cases ppt 4slideshare
Β 
Case Report: Prostate Cancer/Septic Shock
Case Report: Prostate Cancer/Septic ShockCase Report: Prostate Cancer/Septic Shock
Case Report: Prostate Cancer/Septic Shock
Β 
ECTODERMAL DYSPLASIA
ECTODERMAL DYSPLASIAECTODERMAL DYSPLASIA
ECTODERMAL DYSPLASIA
Β 
A case presentation on viral pneumonia
A case presentation on viral pneumoniaA case presentation on viral pneumonia
A case presentation on viral pneumonia
Β 
PTERYGOID HAMULUS SYNDROME- A CASE REPORT
PTERYGOID HAMULUS SYNDROME- A CASE REPORTPTERYGOID HAMULUS SYNDROME- A CASE REPORT
PTERYGOID HAMULUS SYNDROME- A CASE REPORT
Β 
Gestational diabetes case study 2nd one
Gestational diabetes case study 2nd oneGestational diabetes case study 2nd one
Gestational diabetes case study 2nd one
Β 
Diagnostic records /certified fixed orthodontic courses by Indian dental acad...
Diagnostic records /certified fixed orthodontic courses by Indian dental acad...Diagnostic records /certified fixed orthodontic courses by Indian dental acad...
Diagnostic records /certified fixed orthodontic courses by Indian dental acad...
Β 
Case Report: Heparin Induced Thrombocytopenia (HIT)
Case Report: Heparin Induced Thrombocytopenia (HIT)Case Report: Heparin Induced Thrombocytopenia (HIT)
Case Report: Heparin Induced Thrombocytopenia (HIT)
Β 
Ptosis case report
Ptosis case reportPtosis case report
Ptosis case report
Β 
Cardiology case report...an example
Cardiology case report...an exampleCardiology case report...an example
Cardiology case report...an example
Β 
Renal Tumour Angiomyolipoma - Bizarre Presentation
Renal Tumour Angiomyolipoma - Bizarre PresentationRenal Tumour Angiomyolipoma - Bizarre Presentation
Renal Tumour Angiomyolipoma - Bizarre Presentation
Β 
Ectodermal Dysplasia: a case report and overview
Ectodermal Dysplasia: a case report and overview Ectodermal Dysplasia: a case report and overview
Ectodermal Dysplasia: a case report and overview
Β 
Ptosis
PtosisPtosis
Ptosis
Β 
Case report
Case reportCase report
Case report
Β 

Similar to Diabetes Cases.1 Ppt

A practice to diabetes guidelines
A practice to diabetes guidelinesA practice to diabetes guidelines
A practice to diabetes guidelinesWalid Babikr
Β 
Patient counselling on diabetic ketoacidosis
Patient counselling on diabetic ketoacidosis Patient counselling on diabetic ketoacidosis
Patient counselling on diabetic ketoacidosis Dr. Sharad Chand
Β 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitusLih Yin Chong
Β 
Diabetic ketoacidosis: a case study
Diabetic ketoacidosis: a case studyDiabetic ketoacidosis: a case study
Diabetic ketoacidosis: a case studyLyndon Woytuck
Β 
Diabetic Ketoacidosis Case presentation
Diabetic Ketoacidosis Case presentation Diabetic Ketoacidosis Case presentation
Diabetic Ketoacidosis Case presentation Walaa Fahad
Β 
05.Endocrine System 4 Blocks @eduwaves360.pdf
05.Endocrine System 4 Blocks @eduwaves360.pdf05.Endocrine System 4 Blocks @eduwaves360.pdf
05.Endocrine System 4 Blocks @eduwaves360.pdfMahimaChuohan
Β 
casedabetes, dyslip, albu08.05.2017.pptx
casedabetes, dyslip, albu08.05.2017.pptxcasedabetes, dyslip, albu08.05.2017.pptx
casedabetes, dyslip, albu08.05.2017.pptxMariaSobczakKaleta
Β 
Hypoglycemia
HypoglycemiaHypoglycemia
Hypoglycemiayuyuricci
Β 
A young woman with lupus
A young woman with lupusA young woman with lupus
A young woman with lupusEnida Xhaferi
Β 
Hypoglycemia among diabetic patients, 11 Dec 2021.pptx
Hypoglycemia among diabetic patients, 11 Dec 2021.pptxHypoglycemia among diabetic patients, 11 Dec 2021.pptx
Hypoglycemia among diabetic patients, 11 Dec 2021.pptxAhmed Elshebiny
Β 
Board review internal medicine
Board review internal medicineBoard review internal medicine
Board review internal medicineRanjita Pallavi
Β 
Management of diabetes emergencies''
Management of diabetes emergencies''Management of diabetes emergencies''
Management of diabetes emergencies''Musa Ezekiel
Β 
Endocrine Emergencies.pptx
Endocrine Emergencies.pptxEndocrine Emergencies.pptx
Endocrine Emergencies.pptxmunriz
Β 
F inal presentation vernon ems glucometer smr 2015
F inal presentation vernon ems glucometer smr 2015F inal presentation vernon ems glucometer smr 2015
F inal presentation vernon ems glucometer smr 2015cmarth
Β 

Similar to Diabetes Cases.1 Ppt (20)

A practice to diabetes guidelines
A practice to diabetes guidelinesA practice to diabetes guidelines
A practice to diabetes guidelines
Β 
Patient counselling on diabetic ketoacidosis
Patient counselling on diabetic ketoacidosis Patient counselling on diabetic ketoacidosis
Patient counselling on diabetic ketoacidosis
Β 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
Β 
Diabetic ketoacidosis: a case study
Diabetic ketoacidosis: a case studyDiabetic ketoacidosis: a case study
Diabetic ketoacidosis: a case study
Β 
Diabetic Ketoacidosis Case presentation
Diabetic Ketoacidosis Case presentation Diabetic Ketoacidosis Case presentation
Diabetic Ketoacidosis Case presentation
Β 
05.Endocrine System 4 Blocks @eduwaves360.pdf
05.Endocrine System 4 Blocks @eduwaves360.pdf05.Endocrine System 4 Blocks @eduwaves360.pdf
05.Endocrine System 4 Blocks @eduwaves360.pdf
Β 
Diabetic Ketoacidosis
Diabetic KetoacidosisDiabetic Ketoacidosis
Diabetic Ketoacidosis
Β 
casedabetes, dyslip, albu08.05.2017.pptx
casedabetes, dyslip, albu08.05.2017.pptxcasedabetes, dyslip, albu08.05.2017.pptx
casedabetes, dyslip, albu08.05.2017.pptx
Β 
Hypoglycemia
HypoglycemiaHypoglycemia
Hypoglycemia
Β 
Diagnostic Tests of Diabetes
Diagnostic Tests of DiabetesDiagnostic Tests of Diabetes
Diagnostic Tests of Diabetes
Β 
A young woman with lupus
A young woman with lupusA young woman with lupus
A young woman with lupus
Β 
Hypoglycemia among diabetic patients, 11 Dec 2021.pptx
Hypoglycemia among diabetic patients, 11 Dec 2021.pptxHypoglycemia among diabetic patients, 11 Dec 2021.pptx
Hypoglycemia among diabetic patients, 11 Dec 2021.pptx
Β 
CHIKODI IHEKUNA
CHIKODI IHEKUNACHIKODI IHEKUNA
CHIKODI IHEKUNA
Β 
Diabetis mellitus
Diabetis mellitusDiabetis mellitus
Diabetis mellitus
Β 
Hypoglycemia in Adults
Hypoglycemia in AdultsHypoglycemia in Adults
Hypoglycemia in Adults
Β 
Board review internal medicine
Board review internal medicineBoard review internal medicine
Board review internal medicine
Β 
Management of diabetes emergencies''
Management of diabetes emergencies''Management of diabetes emergencies''
Management of diabetes emergencies''
Β 
carbo case reports.pptx
carbo case reports.pptxcarbo case reports.pptx
carbo case reports.pptx
Β 
Endocrine Emergencies.pptx
Endocrine Emergencies.pptxEndocrine Emergencies.pptx
Endocrine Emergencies.pptx
Β 
F inal presentation vernon ems glucometer smr 2015
F inal presentation vernon ems glucometer smr 2015F inal presentation vernon ems glucometer smr 2015
F inal presentation vernon ems glucometer smr 2015
Β 

More from Miami Dade

Pulmonary
PulmonaryPulmonary
PulmonaryMiami Dade
Β 
Psych Lecture 7 Somatoform.1ppt
Psych Lecture 7 Somatoform.1pptPsych Lecture 7 Somatoform.1ppt
Psych Lecture 7 Somatoform.1pptMiami Dade
Β 
7 13 Connective Tissue Disease
7 13 Connective Tissue Disease7 13 Connective Tissue Disease
7 13 Connective Tissue DiseaseMiami Dade
Β 
4 Sle2009
4 Sle20094 Sle2009
4 Sle2009Miami Dade
Β 
5spondyloarthropaties Seronegative Arthritis
5spondyloarthropaties Seronegative Arthritis5spondyloarthropaties Seronegative Arthritis
5spondyloarthropaties Seronegative ArthritisMiami Dade
Β 
Urinary Incontinence
Urinary IncontinenceUrinary Incontinence
Urinary IncontinenceMiami Dade
Β 
Child Infec. Diseases
Child Infec. DiseasesChild Infec. Diseases
Child Infec. DiseasesMiami Dade
Β 
Health Maintenance
Health  MaintenanceHealth  Maintenance
Health MaintenanceMiami Dade
Β 
Presentation Mdc Hematology
Presentation Mdc HematologyPresentation Mdc Hematology
Presentation Mdc HematologyMiami Dade
Β 
Presentation Mdc Nephro Uro
Presentation Mdc Nephro UroPresentation Mdc Nephro Uro
Presentation Mdc Nephro UroMiami Dade
Β 
Pressure Sores
Pressure SoresPressure Sores
Pressure SoresMiami Dade
Β 
Gyn Infections
Gyn  InfectionsGyn  Infections
Gyn InfectionsMiami Dade
Β 
Sports Medicine
Sports MedicineSports Medicine
Sports MedicineMiami Dade
Β 
Presentation Mdc Pulmo
Presentation Mdc PulmoPresentation Mdc Pulmo
Presentation Mdc PulmoMiami Dade
Β 
Lecture 4 Schizophrenia Disorders
Lecture 4 Schizophrenia DisordersLecture 4 Schizophrenia Disorders
Lecture 4 Schizophrenia DisordersMiami Dade
Β 
Skin And Soft Tissue Infections
Skin And Soft Tissue InfectionsSkin And Soft Tissue Infections
Skin And Soft Tissue InfectionsMiami Dade
Β 
Surgery Small Intestine And Appendix T G
Surgery Small Intestine And Appendix  T GSurgery Small Intestine And Appendix  T G
Surgery Small Intestine And Appendix T GMiami Dade
Β 
Lecture 3 Personality Disorders 1
Lecture 3 Personality Disorders 1Lecture 3 Personality Disorders 1
Lecture 3 Personality Disorders 1Miami Dade
Β 
Obgyn Gyn Problems Ii
Obgyn Gyn Problems IiObgyn Gyn Problems Ii
Obgyn Gyn Problems IiMiami Dade
Β 

More from Miami Dade (20)

Pulmonary
PulmonaryPulmonary
Pulmonary
Β 
Psych Lecture 7 Somatoform.1ppt
Psych Lecture 7 Somatoform.1pptPsych Lecture 7 Somatoform.1ppt
Psych Lecture 7 Somatoform.1ppt
Β 
7 13 Connective Tissue Disease
7 13 Connective Tissue Disease7 13 Connective Tissue Disease
7 13 Connective Tissue Disease
Β 
4 Sle2009
4 Sle20094 Sle2009
4 Sle2009
Β 
5spondyloarthropaties Seronegative Arthritis
5spondyloarthropaties Seronegative Arthritis5spondyloarthropaties Seronegative Arthritis
5spondyloarthropaties Seronegative Arthritis
Β 
Urinary Incontinence
Urinary IncontinenceUrinary Incontinence
Urinary Incontinence
Β 
Urology
UrologyUrology
Urology
Β 
Child Infec. Diseases
Child Infec. DiseasesChild Infec. Diseases
Child Infec. Diseases
Β 
Health Maintenance
Health  MaintenanceHealth  Maintenance
Health Maintenance
Β 
Presentation Mdc Hematology
Presentation Mdc HematologyPresentation Mdc Hematology
Presentation Mdc Hematology
Β 
Presentation Mdc Nephro Uro
Presentation Mdc Nephro UroPresentation Mdc Nephro Uro
Presentation Mdc Nephro Uro
Β 
Pressure Sores
Pressure SoresPressure Sores
Pressure Sores
Β 
Gyn Infections
Gyn  InfectionsGyn  Infections
Gyn Infections
Β 
Sports Medicine
Sports MedicineSports Medicine
Sports Medicine
Β 
Presentation Mdc Pulmo
Presentation Mdc PulmoPresentation Mdc Pulmo
Presentation Mdc Pulmo
Β 
Lecture 4 Schizophrenia Disorders
Lecture 4 Schizophrenia DisordersLecture 4 Schizophrenia Disorders
Lecture 4 Schizophrenia Disorders
Β 
Skin And Soft Tissue Infections
Skin And Soft Tissue InfectionsSkin And Soft Tissue Infections
Skin And Soft Tissue Infections
Β 
Surgery Small Intestine And Appendix T G
Surgery Small Intestine And Appendix  T GSurgery Small Intestine And Appendix  T G
Surgery Small Intestine And Appendix T G
Β 
Lecture 3 Personality Disorders 1
Lecture 3 Personality Disorders 1Lecture 3 Personality Disorders 1
Lecture 3 Personality Disorders 1
Β 
Obgyn Gyn Problems Ii
Obgyn Gyn Problems IiObgyn Gyn Problems Ii
Obgyn Gyn Problems Ii
Β 

Recently uploaded

Hi Class Call Girls In Goa 7028418221 Call Girls In Anjuna Beach Escort Services
Hi Class Call Girls In Goa 7028418221 Call Girls In Anjuna Beach Escort ServicesHi Class Call Girls In Goa 7028418221 Call Girls In Anjuna Beach Escort Services
Hi Class Call Girls In Goa 7028418221 Call Girls In Anjuna Beach Escort ServicesApsara Of India
Β 
Call Girls Ellis Bridge 7397865700 Independent Call Girls
Call Girls Ellis Bridge 7397865700 Independent Call GirlsCall Girls Ellis Bridge 7397865700 Independent Call Girls
Call Girls Ellis Bridge 7397865700 Independent Call Girlsssuser7cb4ff
Β 
Amil baba in Pakistan amil baba Karachi amil baba in pakistan amil baba in la...
Amil baba in Pakistan amil baba Karachi amil baba in pakistan amil baba in la...Amil baba in Pakistan amil baba Karachi amil baba in pakistan amil baba in la...
Amil baba in Pakistan amil baba Karachi amil baba in pakistan amil baba in la...Amil Baba Company
Β 
5* Hotel Call Girls In Goa 7028418221 Call Girls In Calangute Beach Escort Se...
5* Hotel Call Girls In Goa 7028418221 Call Girls In Calangute Beach Escort Se...5* Hotel Call Girls In Goa 7028418221 Call Girls In Calangute Beach Escort Se...
5* Hotel Call Girls In Goa 7028418221 Call Girls In Calangute Beach Escort Se...Apsara Of India
Β 
fmovies-Movies hold a special place in the hearts
fmovies-Movies hold a special place in the heartsfmovies-Movies hold a special place in the hearts
fmovies-Movies hold a special place in the heartsa18205752
Β 
Call Girls in Faridabad 9000000000 Faridabad Escorts Service
Call Girls in Faridabad 9000000000 Faridabad Escorts ServiceCall Girls in Faridabad 9000000000 Faridabad Escorts Service
Call Girls in Faridabad 9000000000 Faridabad Escorts ServiceTina Ji
Β 
Call Girl Contact Number Andheri WhatsApp:+91-9833363713
Call Girl Contact Number Andheri WhatsApp:+91-9833363713Call Girl Contact Number Andheri WhatsApp:+91-9833363713
Call Girl Contact Number Andheri WhatsApp:+91-9833363713Sonam Pathan
Β 
Call Girls In Karnal O8860008073 Sector 6 7 8 9 Karnal Escorts
Call Girls In Karnal O8860008073 Sector 6 7 8 9 Karnal EscortsCall Girls In Karnal O8860008073 Sector 6 7 8 9 Karnal Escorts
Call Girls In Karnal O8860008073 Sector 6 7 8 9 Karnal EscortsApsara Of India
Β 
Fun Call Girls In Goa 7028418221 Escort Service In Morjim Beach Call Girl
Fun Call Girls In Goa 7028418221 Escort Service In Morjim Beach Call GirlFun Call Girls In Goa 7028418221 Escort Service In Morjim Beach Call Girl
Fun Call Girls In Goa 7028418221 Escort Service In Morjim Beach Call GirlApsara Of India
Β 
Hot Call Girls In Goa 7028418221 Call Girls In Vagator Beach EsCoRtS
Hot Call Girls In Goa 7028418221 Call Girls In Vagator Beach EsCoRtSHot Call Girls In Goa 7028418221 Call Girls In Vagator Beach EsCoRtS
Hot Call Girls In Goa 7028418221 Call Girls In Vagator Beach EsCoRtSApsara Of India
Β 
NO1 WorldWide Amil baba in pakistan Amil Baba in Karachi Black Magic Islamaba...
NO1 WorldWide Amil baba in pakistan Amil Baba in Karachi Black Magic Islamaba...NO1 WorldWide Amil baba in pakistan Amil Baba in Karachi Black Magic Islamaba...
NO1 WorldWide Amil baba in pakistan Amil Baba in Karachi Black Magic Islamaba...Amil baba
Β 
Authentic No 1 Amil Baba In Pakistan Authentic No 1 Amil Baba In Karachi No 1...
Authentic No 1 Amil Baba In Pakistan Authentic No 1 Amil Baba In Karachi No 1...Authentic No 1 Amil Baba In Pakistan Authentic No 1 Amil Baba In Karachi No 1...
Authentic No 1 Amil Baba In Pakistan Authentic No 1 Amil Baba In Karachi No 1...First NO1 World Amil baba in Faisalabad
Β 
Gripping Adult Web Series You Can't Afford to Miss
Gripping Adult Web Series You Can't Afford to MissGripping Adult Web Series You Can't Afford to Miss
Gripping Adult Web Series You Can't Afford to Missget joys
Β 
Udaipur Call Girls 9602870969 Call Girl in Udaipur Rajasthan
Udaipur Call Girls 9602870969 Call Girl in Udaipur RajasthanUdaipur Call Girls 9602870969 Call Girl in Udaipur Rajasthan
Udaipur Call Girls 9602870969 Call Girl in Udaipur RajasthanApsara Of India
Β 
Kolkata Call Girl Bagbazar πŸ‘‰ 8250192130 β£οΈπŸ’― Available With Room 24Γ—7
Kolkata Call Girl Bagbazar πŸ‘‰ 8250192130 β£οΈπŸ’― Available With Room 24Γ—7Kolkata Call Girl Bagbazar πŸ‘‰ 8250192130 β£οΈπŸ’― Available With Room 24Γ—7
Kolkata Call Girl Bagbazar πŸ‘‰ 8250192130 β£οΈπŸ’― Available With Room 24Γ—7Riya Pathan
Β 
Call Girl Price Andheri WhatsApp:+91-9833363713
Call Girl Price Andheri WhatsApp:+91-9833363713Call Girl Price Andheri WhatsApp:+91-9833363713
Call Girl Price Andheri WhatsApp:+91-9833363713Sonam Pathan
Β 
Vip Udaipur Call Girls 9602870969 Dabok Airport Udaipur Escorts Service
Vip Udaipur Call Girls 9602870969 Dabok Airport Udaipur Escorts ServiceVip Udaipur Call Girls 9602870969 Dabok Airport Udaipur Escorts Service
Vip Udaipur Call Girls 9602870969 Dabok Airport Udaipur Escorts ServiceApsara Of India
Β 
ViP Call Girls In Udaipur 9602870969 Gulab Bagh Escorts SeRvIcE
ViP Call Girls In Udaipur 9602870969 Gulab Bagh Escorts SeRvIcEViP Call Girls In Udaipur 9602870969 Gulab Bagh Escorts SeRvIcE
ViP Call Girls In Udaipur 9602870969 Gulab Bagh Escorts SeRvIcEApsara Of India
Β 

Recently uploaded (20)

Hi Class Call Girls In Goa 7028418221 Call Girls In Anjuna Beach Escort Services
Hi Class Call Girls In Goa 7028418221 Call Girls In Anjuna Beach Escort ServicesHi Class Call Girls In Goa 7028418221 Call Girls In Anjuna Beach Escort Services
Hi Class Call Girls In Goa 7028418221 Call Girls In Anjuna Beach Escort Services
Β 
Call Girls Ellis Bridge 7397865700 Independent Call Girls
Call Girls Ellis Bridge 7397865700 Independent Call GirlsCall Girls Ellis Bridge 7397865700 Independent Call Girls
Call Girls Ellis Bridge 7397865700 Independent Call Girls
Β 
Amil baba in Pakistan amil baba Karachi amil baba in pakistan amil baba in la...
Amil baba in Pakistan amil baba Karachi amil baba in pakistan amil baba in la...Amil baba in Pakistan amil baba Karachi amil baba in pakistan amil baba in la...
Amil baba in Pakistan amil baba Karachi amil baba in pakistan amil baba in la...
Β 
5* Hotel Call Girls In Goa 7028418221 Call Girls In Calangute Beach Escort Se...
5* Hotel Call Girls In Goa 7028418221 Call Girls In Calangute Beach Escort Se...5* Hotel Call Girls In Goa 7028418221 Call Girls In Calangute Beach Escort Se...
5* Hotel Call Girls In Goa 7028418221 Call Girls In Calangute Beach Escort Se...
Β 
fmovies-Movies hold a special place in the hearts
fmovies-Movies hold a special place in the heartsfmovies-Movies hold a special place in the hearts
fmovies-Movies hold a special place in the hearts
Β 
Call Girls in Faridabad 9000000000 Faridabad Escorts Service
Call Girls in Faridabad 9000000000 Faridabad Escorts ServiceCall Girls in Faridabad 9000000000 Faridabad Escorts Service
Call Girls in Faridabad 9000000000 Faridabad Escorts Service
Β 
Call Girl Contact Number Andheri WhatsApp:+91-9833363713
Call Girl Contact Number Andheri WhatsApp:+91-9833363713Call Girl Contact Number Andheri WhatsApp:+91-9833363713
Call Girl Contact Number Andheri WhatsApp:+91-9833363713
Β 
Call Girls In Karnal O8860008073 Sector 6 7 8 9 Karnal Escorts
Call Girls In Karnal O8860008073 Sector 6 7 8 9 Karnal EscortsCall Girls In Karnal O8860008073 Sector 6 7 8 9 Karnal Escorts
Call Girls In Karnal O8860008073 Sector 6 7 8 9 Karnal Escorts
Β 
Fun Call Girls In Goa 7028418221 Escort Service In Morjim Beach Call Girl
Fun Call Girls In Goa 7028418221 Escort Service In Morjim Beach Call GirlFun Call Girls In Goa 7028418221 Escort Service In Morjim Beach Call Girl
Fun Call Girls In Goa 7028418221 Escort Service In Morjim Beach Call Girl
Β 
Hot Call Girls In Goa 7028418221 Call Girls In Vagator Beach EsCoRtS
Hot Call Girls In Goa 7028418221 Call Girls In Vagator Beach EsCoRtSHot Call Girls In Goa 7028418221 Call Girls In Vagator Beach EsCoRtS
Hot Call Girls In Goa 7028418221 Call Girls In Vagator Beach EsCoRtS
Β 
Call Girls Koti 7001305949 all area service COD available Any Time
Call Girls Koti 7001305949 all area service COD available Any TimeCall Girls Koti 7001305949 all area service COD available Any Time
Call Girls Koti 7001305949 all area service COD available Any Time
Β 
NO1 WorldWide Amil baba in pakistan Amil Baba in Karachi Black Magic Islamaba...
NO1 WorldWide Amil baba in pakistan Amil Baba in Karachi Black Magic Islamaba...NO1 WorldWide Amil baba in pakistan Amil Baba in Karachi Black Magic Islamaba...
NO1 WorldWide Amil baba in pakistan Amil Baba in Karachi Black Magic Islamaba...
Β 
Authentic No 1 Amil Baba In Pakistan Authentic No 1 Amil Baba In Karachi No 1...
Authentic No 1 Amil Baba In Pakistan Authentic No 1 Amil Baba In Karachi No 1...Authentic No 1 Amil Baba In Pakistan Authentic No 1 Amil Baba In Karachi No 1...
Authentic No 1 Amil Baba In Pakistan Authentic No 1 Amil Baba In Karachi No 1...
Β 
Gripping Adult Web Series You Can't Afford to Miss
Gripping Adult Web Series You Can't Afford to MissGripping Adult Web Series You Can't Afford to Miss
Gripping Adult Web Series You Can't Afford to Miss
Β 
Udaipur Call Girls 9602870969 Call Girl in Udaipur Rajasthan
Udaipur Call Girls 9602870969 Call Girl in Udaipur RajasthanUdaipur Call Girls 9602870969 Call Girl in Udaipur Rajasthan
Udaipur Call Girls 9602870969 Call Girl in Udaipur Rajasthan
Β 
Kolkata Call Girl Bagbazar πŸ‘‰ 8250192130 β£οΈπŸ’― Available With Room 24Γ—7
Kolkata Call Girl Bagbazar πŸ‘‰ 8250192130 β£οΈπŸ’― Available With Room 24Γ—7Kolkata Call Girl Bagbazar πŸ‘‰ 8250192130 β£οΈπŸ’― Available With Room 24Γ—7
Kolkata Call Girl Bagbazar πŸ‘‰ 8250192130 β£οΈπŸ’― Available With Room 24Γ—7
Β 
Call Girl Price Andheri WhatsApp:+91-9833363713
Call Girl Price Andheri WhatsApp:+91-9833363713Call Girl Price Andheri WhatsApp:+91-9833363713
Call Girl Price Andheri WhatsApp:+91-9833363713
Β 
Vip Udaipur Call Girls 9602870969 Dabok Airport Udaipur Escorts Service
Vip Udaipur Call Girls 9602870969 Dabok Airport Udaipur Escorts ServiceVip Udaipur Call Girls 9602870969 Dabok Airport Udaipur Escorts Service
Vip Udaipur Call Girls 9602870969 Dabok Airport Udaipur Escorts Service
Β 
young call girls in Hari Nagar,πŸ” 9953056974 πŸ” escort Service
young call girls in Hari Nagar,πŸ” 9953056974 πŸ” escort Serviceyoung call girls in Hari Nagar,πŸ” 9953056974 πŸ” escort Service
young call girls in Hari Nagar,πŸ” 9953056974 πŸ” escort Service
Β 
ViP Call Girls In Udaipur 9602870969 Gulab Bagh Escorts SeRvIcE
ViP Call Girls In Udaipur 9602870969 Gulab Bagh Escorts SeRvIcEViP Call Girls In Udaipur 9602870969 Gulab Bagh Escorts SeRvIcE
ViP Call Girls In Udaipur 9602870969 Gulab Bagh Escorts SeRvIcE
Β 

Diabetes Cases.1 Ppt

  • 1. Jimmy Santana, MBA, P.A. - C 1 3/13/2009
  • 2.
  • 3. ο‚— A 24-year-old, white female has recently being diagnosed with insulin-dependent diabetes. The disease is being managed on a split dose of 60/40 insulin suspension, which she injects herself at 8:00 a.m. and 5:00 p.m. She was told to call in if she experiences any strange symptoms, which she does this afternoon. At 2:45 p.m. she is not feeling well and notices that her skin is cool and damp. Her hands are shaking and she is very anxious. What do you tell her to do right away, before having somebody take her to your office? ο‚— A. Inject 4 IU of her insulin ο‚— B. Drink a can of diet soda ο‚— C. Drink six ounces of fruit juice ο‚— D. Eat a large candy bar ο‚— E. Eat a cube of sugar
  • 4. ο‚— The above described symptoms are classical for hypoglycemia. An inexperienced patient needs to be monitored by medical personnel until the blood glucose level is stabilized again. The first priority though is to prevent the blood sugar to drop any further and send the patient into a coma. ο‚— A six-ounce drink of fruit juice should be sufficient. Since the symptoms suggest hypoglycemia, injecting insulin would worsen the situation. If in doubt if the patient is hypo- or hyperglycemic and there is no possibility for a test, always give sugar first and see if the patient improves. An increase of a blood glucose level of, for example, 350 is not going to hurt the patient, but lowering a level of 45 is going to send the diabetic into a coma. ο‚— Since diet soda contains only sugar substitutes it is not going to influence the blood glucose level. A large candy bar could be eaten too, but it may raise the glucose level higher than required, therefore the fruit juice is a better choice. One cube of sugar is an insufficient amount to raise blood sugar; it will take several cubes.
  • 5. ο‚— A 61-year-old white male presents to your office for the first time. In reviewing his medical records, you note a history of diabetes type 2 onset 4 years ago. He is currently well controlled to normal blood sugars and hemoglobin A1Cs. You do note that his previous blood pressure readings were above normal on multiple visits. In addition to his usual diabetic care, you recommend initiation of drug therapy for his hypertension. Your drug of choice is ο‚— A. Calcium channel blocker ο‚— B. ACE inhibitor ο‚— C. Alpha blocker ο‚— D. Thiazide diuretic ο‚— E. Beta blocker
  • 6. ο‚— ACE inhibitors have been shown to slow the progress of proteinuria in patients with diabetes. Control of their blood pressure is just as important. Your drug of choice should be an ACE inhibitor for any diabetic with hypertension as long as there are no contraindications to giving them this medicine.
  • 7. A 55-year-old male is brought into the urgent care center of your hospital by paramedics. He is 3. obtunded, and today his wife could not get him out of bed. He has no significant past medical history. His wife states that he has not been well for the last week, with decreased energy and fatigue. In addition, he has had a productive cough, which has worsened during the last 3 days. Also, according to his wife, he appears to be drinking more water. Physical exam reveals a lethargic male who moves to deep pain but has no intelligible speech. Paramedics have given the patient Narcan with no change in his status but have withheld glucose bolus due to a high dextro stick reading. Vital signs are pulse 115; BP 90/50; respiration 18; Temp 38.2Β° C (100.7Β° F) HEENT shows dry mucous membranes. Lungs are clear. Cardiac exam is significant for tachycardia. ο‚— Abdominal exam is nonspecific. Neurologic exam shows the patient to be responsive only to pain, with withdrawal. No abnormal reflexes noted. Initial laboratory studies show: Na 118; K 4.2; Cl 97; HCO3 21; Glucose 1050. ABG reveals pH 7.34, pCO2 ο‚— 20; pO2 79; O2 saturation 90%. CBC shows a normal H/H with WBC count of 14K; the serum is reported as very lipemic. Chest X-ray shows an LLL consolidation. The most likely cause for the change in the patient's mental status is A. Acute diabetic ketoacidosis ο‚— B. Pseudohyponatremia ο‚— C. Pneumococcal pneumonia with hypoxia ο‚— D. Hyperglycemic hyperosmolar nonketotic coma ο‚— E. Central pontine myelinolysis ο‚—
  • 8. ο‚— Hyperglycemic hyperosmolar nonketotic coma (HHNC) represents a syndrome characterized by marked hyperglycemia, hyperosmolarity, and dehydration. It is manifested by decreased mental functioning that may progress to frank coma. Ketosis and acidosis are generally minimal. DKA, acute diabetic ketoacidosis, will have similar electrolyte ο‚— abnormalities; however, there will be an associated metabolic acidosis and ketosis. The patient does show pseudohyponatremia, which is due to the presence ο‚— of hyperglycemia and hyperlipidemia. In the absence of marked lipemia, the true value for sodium can be approximated by adding 1.3 to 1.6 mEq/L to the sodium value for every 100 mg/dl glucose over the norm. But this is not the cause of this patient's altered sensorium. The patient most likely has pneumococcal pneumonia, which is a ο‚— common precipitating factor in the development of HHNC. He is mildly hypoxic, though this does not explain the degree of obtundation seen. Overly aggressive restoration of serum sodium levels in hyponatremic ο‚— patients can be associated with central pontine myelinolysis and circulatory overload.
  • 9. ο‚— A 28-year-old type I diabetic on multiple daily insulin injections regimen presents to your office for a follow up visit. She complained to you about her early morning glucose level during her last visit and you recommended for her to chart the numbers and bring it for her next appointment. Her pre- breakfast glucose averaged 285mg/dL; dinnertime was 95mg/dL and 68mg/dL at 3 AM. How will you treat her diabetes? ο‚— A. Increase the evening dose of long acting insulin ο‚— B. Decrease the evening dose of long acting insulin ο‚— C. Decrease the evening dose of short acting insulin ο‚— D. Increase the evening dose of short acting insulin ο‚— E. Increased activity before bedtime
  • 10. ο‚— Three mechanisms can account for early morning hyperglycemia in patients with diabetes on insulin: 1. Inadequate dose of long acting insulin at night 2. Somogyi effect or rebound hyperglycemia is a condition often seen in type I diabetes, in which there is nocturnal hypoglycemia. The hypoglycemia subsequently stimulates the release of counter regulatory hormones leading to increase of glucose level in the blood. Diagnosis can be made by several plasma glucose analyses done at 2.00 A.M, 3.00 A.M, and 7.00A.M. 3. In the dawn phenomenon, the hyperglycemia is secondary to increased need for insulin in the early morning due to the normal early morning surge of growth hormone, which antagonizes insulin action. ο‚— Checking the blood glucose level at 3 AM can help differentiate between Somogyi effect and dawn phenomenon: the level will be low in Somogyi phenomenon. The patient's early morning hyperglycemia is due to Somogyi effect since her 3 AM level was low. Treatment of this will be to decrease the evening dose of long-acting insulin or give bedtime snacks. The treatment of dawn phenomenon involves increasing the evening dose of long-acting insulin. ο‚— There is no nocturnal hypoglycemia if the night dose of insulin is inadequate.
  • 11. A 62-year-old male with a history of diabetes for twenty-five years and hypertension for ο‚— ten years is referred to your office by a retired physician. He complains of worsening edema on the right lower extremity during the last two weeks. Vital signs show T 97.8 Pulse 78 RR 20 BP 165/93. Physical examination disclosed periorbital edema and left lower extremity edema 1+ below the knee and right lower extremity edema 3+ below the knee that is nontender to palpation. He denies any fever, chills, or malaise. He is currently on glipizide 20 mg twice a day and amlodipine 10-mg once daily. Laboratory result from two weeks ago shows Na 145, K 4.5, Cl 102, HCO3 25, BUN 14, Creat 1.2, CA 7.2, Glucose 287, HgA1C 8.6, and Albumin 2.5. The U/A test shows 3+ proteins with no WBC or RBC. Question: What is the most appropriate next step in management of his diabetes? A. Start the patient on glyburide ο‚— B. Start the patient on insulin therapy ο‚— C. There is no indication to change his diabetes therapy. His HgA1C shows that his ο‚— diabetes is under control D. Start the patient on metformin ο‚— E. Repeat the patient's HgbA1C; result is too old to reflect the current HgbA1C level ο‚—
  • 12. ο‚— This patient's diabetes mellitus is poorly managed. Glycosylated hemoglobin (HbA1c) is the best indicator of glycemic control over the previous 3 months. Maintaining an HgA1C of 7 or less lowers the rate of complications of diabetes mellitus. Adding a second class of oral hypoglycemic agent would be the next best choice. Metformin is the drug from the biguanides class; therefore, it is the drug of choice. ο‚— Starting the patient on glyburide is incorrect because both glyburide and glipizide belong to the sulfonylurea class. Starting the patient on insulin therapy is incorrect because oral therapy should be maximized before starting on insulin. HgA1c of 8.6 indicates poorly controlled diabetes. There is a need to change his diabetes management. There is no need to repeat HgA1C. Glycosylated hemoglobin (HbA1C) is the best indicator of glycemic control over the previous 3 months. The result is not too old.
  • 13. ο‚— A 38-year-old obese female with type 2 diabetes mellitus presents to your office for follow up visit. Her blood sugar has been well controlled on metformin. She wants to have a baby and wants to know if there is any special thing to do so that her diabetes will not affect her pregnancy. Which of the following is appropriate for her? ο‚— A. Switch her to insulin ο‚— B. Switch to glyburide ο‚— C. Tell her it is not advisable for her to be pregnant because her child will be diabetic ο‚— D. Increase the dose of her metformin to prevent worsening of her blood sugar during pregnancy ο‚— E. Continue her present treatment and dose
  • 14. ο‚— Diabetic patients that are pregnant or attempting to get pregnant, irrespective of whether they are insulin requiring or not, should be switched to insulin therapy for their glucose control. Oral glucose lowering agents are contraindicated in pregnancy. Although a poor glucose control predisposes to increased maternal and fetal risks, it is not a contraindication to pregnancy. A good glucose control is however necessary prior to and during pregnancy.
  • 15.
  • 16. ο‚— A 24-year old white male present to the flight physician assistant’s office for a routine physical. He has been taking flying lessons and is applying for a pilot’s license. Regulations state that he must have a physical examination. ο‚— Examination discloses a thin male, 74 inches, 140 pounds. Generally, the exam is unremarkable. Routine screening includes a urinalysis, which demonstrates 4+ glycouria. 16 3/13/2009
  • 17. There is insufficient information to establish a diagnosis. ο‚— There are other reasons to spill glucose in the urine. You must ask additional questions. You find out that even though he denies any history of ο‚— diabetes, he admits to: Having incessant thirst 1. Increase hunger 2. Increase urination 3. He has lost 15 pounds over the last three months 4. 17 3/13/2009
  • 18. ο‚— A glucometer reading revealed a glucose of 490 mg/dl ο‚— A blood glucose revealed a glucose level of 496 mg/dl. With normal electrolytes and anion gap ο‚— Does this patient have diabetes? 18 3/13/2009
  • 19. ο‚— Three ways to diagnose diabetes mellitus: ο‚— Fasting glucose of > 126 mg/dl ο‚— Oral glucose tolerance test with a 2 hr value of > 200 and one other value in-between of > 200 ο‚— Grossly elevated serum glucose with classic signs and 19 3/13/2009
  • 20. ο‚— New onset Type I diabetics should be admitted because: ο‚— He needs to start on insulin ο‚— He requires a lot of patient education 20 3/13/2009
  • 21. ο‚— 32-year old woman who has type I diabetes calls you over the weekend. She has been having some nausea and vomiting for the last 24 hours and can not keep solids down. She has been able to keep liquids down. Her last glucometer reading was 261 mg/dl. ο‚— She is on a split dose of NPH and regular insulin twice daily. She did not take her morning insulin because a physician had told her never to take her insulin when she is not eating. She ask you for instructions? 21 3/13/2009
  • 22. ο‚— Many patients do not take their insulin if they are not eating; this is wrong. ο‚— It is important for IDDM patients and their providers to learn how to manage β€œsick days”. ο‚— Note that one of the most common reasons for patient to go into DKA is poor management of their diabetes when they are sick. ο‚— Insulin should be taken regardless of whether or not they are eating ο‚— Adequate carbohyrates should be taken (15 – 20g q2h) 22 3/13/2009
  • 23. ο‚— The patient can consume regular coke, Sprite, juices @ 4 – 6 oz q2hrs. They can also have gelatin, crackers, soup ο‚— Patients that are sick require more insulin ο‚— NOT less The intermediate or long acting insulin should ο‚— be given Regular insulin should be given q4h as per a ο‚— β€˜sliding scale’ 23 3/13/2009
  • 24. ο‚— 69-year old white female was in good health until 3 weeks ago, when she suddenly developed severe polyuria, polydipsia and polyphagia. She has lost 20 pounds ( going from 120 to 100) during that period and feels extremely weak. When her daughter brings her to you, in the ED, she is somewhat lethargic. Past medical history reveals HTN(Tx with a small dose of enalapril). There is no history of cardiac disease. 24 3/13/2009
  • 25. ο‚— Physical Exam reveals a pale, lethargic, confused woman, breathing rapidly. ο‚— B/P is 102/72 P 110 Resp 32 ο‚— Her skin is very dry, bowel sounds are weakly positive ο‚— Blood test revealed Na+ 130 (135 – 145) ο‚— K+ 5.1 (3.5 – 5.1) ο‚— Glucose 794 ( 70 – 110) ο‚— Cl- 104 (95 – 105) ο‚— HCO3 3mEq/L (21 – 30) ο‚— pH 6.92 (7.35 – 7.45) ο‚— pO2 92 mm (80 – 105) ο‚— 25 3/13/2009
  • 26. ο‚— A 37 year old white female has a 20 year history of diabetes mellitus. She has been having difficulty with hypoglycemia in the early morning. She used to be on beef-pork insulin and did not have any problems. ο‚— She takes: ο‚— Human NPH 16U am; 8 U pm ο‚— Human Regular 8 U am; 3 U pm 26 3/13/2009
  • 27. ο‚— Blood glucose monitoring reveal: 3am 7am 12pm 5pm 41 66 109 72 47 132 82 100 35 182 134 142 ο‚— Why is she developing early-morning hypoglycemia? 27 3/13/2009
  • 28. ο‚— Insulin have different peaks and duration of action. ο‚— In this case you must note that animal insulin has a slower peak than human insulin ο‚— In this case this lady was advised to move the NPH evening dose to qhs --- which allowed the NPH peak to occur later ο‚— To cover the evening problem one should also increase the bedtime regular insulin --- in this case it was increased by 2 U 28 3/13/2009
  • 29. ο‚— A 56-year male has a history of type II diabetes for 10 years. He is currently on glipizde 20 mg BID and monitors his glucose twice a day. Over the last 2 weeks his fasting glucose were 157 – 278 (average 199); supper values were 145 – 292 (average 212). 29 3/13/2009
  • 30. ο‚— Yesterday his fasting glucose was 234 and HgA1c was 14.8% ο‚— P.E.: B/P 142/90 P 72 Resp. 12 height:72 inches weight: 212 ο‚— The rest of the physical was normal with no evidence of retinopathy or neuropathy ο‚— What is the best option for this patient? 30 3/13/2009
  • 31. ο‚— Though this patient may not want to go on insulin …. We have no choice. ο‚— He has unacceptably high glucose values ο‚— HgA1C confirms the fact that insulin is needed ο‚— What do we start him on? 31 3/13/2009
  • 32. ο‚— Many clinicians start their type II that now require insulin on NPH or ultralente and add regular insulin later as needed to tune – up treatment. ο‚— After knowing what it would take to treat this patient --- you may then decide to use pre- mixed insulin. ο‚— Should this patient be hospitalized? ο‚— No 32 3/13/2009
  • 33. ο‚— A 30-year female has no prior medical problems. As part of a routine obstetric care, she has a glucose screen at 24 weeks. She is given 50-g glucose to drink and a glucose level is obtained 1 hour later. Her results revealed a level of 156 mg (<140) ο‚— She is 64 inches tall and weighs 220 ο‚— What do you do know? 33 3/13/2009
  • 34. ο‚— You should now order a 3 hr GTT, which they give 100 g of glucose ο‚— Her results were ο‚— Fasting: 112mg ο‚— 1hour: 183mg ο‚— 2hour: 172mg ο‚— 3hour: 147mg ο‚— What is your opinion? 34 3/13/2009
  • 35. ο‚— This patient has Gestational Diabetes. According to the National Diabetes Data Group – Dx is made if two or more values exceed the norm. ο‚— You should start this patient on a ADA 2000 calorie diet, give her a glucometer(she to take readings four times daily) and see her in a week. 35 3/13/2009
  • 36. ο‚— You see her back in a week and her glucose log reveal: Fasting LunchSupper Bedtime 97 93 115 104 112 101 107 99 101 101 89 122 93 105 102 111 115 112 121 118 99 107 113 105 96 101 117 109 36 3/13/2009
  • 37. ο‚— What should you do now? ο‚— This patient should be started on insulin. Though these level appear good; in pregnancy glucose levels are significantly lower. ο‚— Target glucose goals are: Fasting: 60 – 90 ο‚— Non-fasting (before breakfast) 60 – 105 ο‚— After meals: < 120 ο‚— 2am – 6am: >60 ο‚— 37 3/13/2009
  • 38. ο‚— Since most of these patients seem to be insulin resistant it is recommended to start with 0.6U/kg/day. In this patient we would give 30 – 32 U NPH (or Longer acting) BID. She returns in four days with the following readings: Fasting LunchSupper Bedtime 93 99 97 122 86 100 98 113 74 78 99 107 68 90 79 112 38 3/13/2009
  • 39. ο‚— How is our patient doing? ο‚— These reading show that we still have a problem at bedtime. Therefore, we should add 2U of regular insulin in the evenings 39 3/13/2009
  • 41. A 58 year-old man with a 12 year history of type 2 diabetes comes to your office because of an ulcer in his right foot. Physical exam reveals a 1-cm irregular ulceration over the right metatarsal head, surrounded by an area of black gangrenous skin. The patient is admitted and undergoes amputation of the right forefoot. Which of the following would have been most effective in preventing this complication? Appropriate instructions on self-care of the feet A. B. Doppler exam of the lower extremities C. Nuerophysiologic and electromyographic studies D. Local application of platelet-derived growth factor E. Prophylactic treatment with cholesterol-lowering agents 41
  • 42. Screening 1. Current guidelines 2. Use of oral agents 3. Insulin regimens 4. Gestational diabetes 5. 42
  • 43. 45 years old; repeat q 3 years ο‚— Overweight (BMI 25 kg/m2*) ο‚— Physically inactive ο‚— Have a first-degree relative with diabetes ο‚— High-risk ethnic population ο‚— h/o GDM or baby >9 lbs ο‚— HTN ο‚— Hyperlipidemia ο‚— PCOS ο‚— Other sx of insulin resistance (acanthosis) ο‚— h/o vascular disease ο‚— 43
  • 44. Symptoms of diabetes and a casual plasma glucose 200 mg/dl or.. 1. FPG 126 mg/dl ( no caloric intake for at least 8 hr) or… 2. BS 200 mg/dl after OGTT (2 hr after 75 gm glucose). 3. In the absence of unequivocal hyperglycemia, these ο‚— criteria should be confirmed by repeat testing on a different day. OGTT is not recommended for routine clinical ο‚— use, but may be required in the evaluation of patients with IFG or when diabetes is still suspected despite a normal FPG as with the postpartum evaluation of women with GDM. 44
  • 45. A1C<7.0% (q 3 mo if uncontrolled; twice yr if at goal) ο‚— Preprandial BS 80-110 mg/dl (60-90 if pregnant) ο‚— Postprandial BS<140 mg/dl (<120 if pregnant) ο‚— Blood pressure<130/80 mmHg ο‚— LDL<100 mg/dl ο‚— Triglycerides <150 mg/dl ο‚— HDL>40 mg/dl ο‚— Annual influenza vaccine ο‚— Pneumococcal vaccine for adults with diabetes ο‚— Revaccination is for individuals >64 if vaccine was ο‚— administered >5 years ago. Other indications for repeat vaccination include nephrotic syndrome, chronic renal disease, and other immunocompromised states, such as after transplantation. 45
  • 46. ο‚— SMBG TID w/ DM1 and GDM ο‚— BP each visit ο‚— Annual urinary microalbumin (<30ug/mg) ο‚— Annual lipids ο‚— Annual optho exam starting 3-5 yrs after onset w/ DM1, and upon diagnosis in DM 2 ο‚— Visual foot exam each visit. Comprehensive exam yearly (sensation, biomechanics, foot structure, vascular status and skin integrity) 46
  • 47. 47
  • 48. ο‚— Risk assessment at first prenatal visit ο‚— Low-risk status requires no glucose testing οƒ˜ Age <25 years οƒ˜ Weight normal before pregnancy οƒ˜ Member of an ethnic group with low prevalence οƒ˜ No known diabetes in first-degree relatives οƒ˜ No history of abnormal glucose tolerance οƒ˜ No history of poor obstetric outcome ο‚— High risk features (obesity, h/o GDM, glycosuria, or FH) should undergo glucose testing as soon as possible 48
  • 49. ο‚— FPG 126 mg/dl or a casual plasma glucose 200 mg/dl meets the threshold for the diagnosis of diabetes (confirm on subsequent day) ο‚— High-risk women not found to have GDM at initial screening and average- risk women should be tested between 24 and 28 weeks of gestation. Testing should follow one of two approaches: One-step approach: 100-g OGTT ο‚— οƒ˜ 95 mg/dl fasting οƒ˜ 180 mg/dl at 1 h οƒ˜ 155 mg/dl at 2 h and 140 mg/dl at 3 h. *Two or more of the plasma glucose values must be met or exceeded for a positive diagnosis ο‚— Two-step approach: perform an initial screening by measuring the plasma or serum glucose concentration 1 h after a 50-g oral glucose load and perform a diagnostic 100-g OGTT on that subset of women exceeding 140 mg/dl 49
  • 50. Drug Class Mechanism of Action Side Effects ↑insulin secretion Sulfonylureas/ secretagogues weight gain, hypoglycemia ↓hepatic glucose output Metformin GI upset, lactic acidosis, TZD’s ↑ peripheral glucose fluid retention, weight gain disposal ↓ intestinal Alpha-glucosidase inhibitors flatulence, diarrhea carbohydrate absorption *Each will lower A1c by 1-2% compared to placebo. When combined, efficacy typically is additive 50
  • 51. Sulfonylurea + Metformin Sulfonylurea + Ξ±-glucosidase inhibitors Sulfonylurea + TZD Metformin + Secretagogues Metformin + TZD Insulin + Sulfonylurea Insulin + Metformin Insulin + TZD 51
  • 52. ο‚— Know the types of insulin and onset ο‚— Know how to adjust insulin ο‚— All regimens include basal and bolus 52
  • 53. β€’Make changes slowly, taking into account diet, activity, stress β€’Asses the effectiveness of insulin at its peak time of action β€’Increase short/rapid insulin based on post-prandial readings β€’Increase long-acting when BG high fasting or throughout day β€’Inject into subcutaneous abdomen and rotate sites 53
  • 54. ο‚— To ↓ pre-dinner BG…….↑AM intermediate-acting (e.g., NPH) ο‚— To ↓ fasting BG……….. ↑PM long/intermediate-acting insulin (e.g., glargine, NPH) ο‚— To ↓ pre-lunch BG……..↑AM short/rapid-acting insulin (e.g., regular, lispro, aspart) ο‚— To ↓ bedtime BG…...….↑PM short/rapid-acting insulin (regular, lispro, aspart) 54 3/13/2009
  • 55. ο‚— Onset within 24 hours ο‚— Diabetic ketoacidosis DKA ο‚— usually seen with Type 1 ο‚— Liver cannot metabolize and kidneys cannot excrete ο‚— Hyperglycemia (>250) ο‚— Ketosis (positive urine dipstick) ο‚— Metabolic acidosis (HCO3 < 15; pH <7.3) ο‚— May mimic β€œflu” Polyuria, polydipsia, nausea, vomiting, abdominal pain, breath smells like booze.
  • 56. Decreased insulin, high counterregulatory hormones (catecholamines, glucagon, GH, cortisol), leading to hyperglycemia, proteolysis, lipolysis & ketone production Diagnostic Criteria hyperglycemia: glucose>250 mg/dl ο‚— acidosis: pH <7.35; HCO3 < 18 ο‚— ketosis (blood &/or urine) ο‚— Therapeutic Goals Improve circulating volume & tissue perfusion ο‚— Identify precipitating factors ο‚— FLUIDS restores intravascular volume, decreases ο‚— counterregulatory hormones and lowers glucose levels Reduce Gluc. & serum osmolarity: lytes q2, glucose q1 ο‚— Clear ketones, fix electrolytes ο‚— 56
  • 57. ο‚— HHNK - Hyperglycemic, hyperosmolar, non- ketotic coma. Onset 2 days to 2 weeks. ο‚— Osmolarity > 310 ο‚— Glucose > 600 ο‚— Usually seen with Type 2 ο‚— exhibiting increasing insulin resistance, esp. after gorging on CHO. ο‚— Presents with marked dehydration and CNS SSx often mimicking a stroke. ο‚— Must correct S-L-O-W-L-Y to prevent cerebral edema. Watch K+ levels.
  • 58. ο‚— Hypoglycemia ο‚— Glucose < 50 ο‚— Causes: ο‚— Not enough to eat (or forgot) ο‚— Too much insulin (or pills) ο‚— Did not allow for exercise ο‚— CNS- confusion, delirium, coma ο‚— Autonomic - hunger, anxiety, SWEATING, tachycardia. ο‚— If patient is conscious - give OJ. Otherwise injection of glucagon, glucose gel in mouth, or 50% glucose by IV push.
  • 59. ο‚— Neuropathies - peripheral ο‚— Obstruction of vessels that supply nerves ο‚— Demyelination ο‚— Sensory ο‚— Paresthesias ο‚— Decreased sensitivity to pain, temperature and light touch. ο‚— Decreased proprioception and vibration sense. ο‚— Motor ο‚— Weakness ο‚— Atrophy
  • 60. ο‚— Neuropathies - central and autonomic ο‚— orthostatic hypotension ο‚— gastrointestinal atony ο‚— atonic urinary bladder ο‚— impotence ο‚— impairment of special senses
  • 61. ο‚— Nephropathy Glomerulosclerosis (arteriolonephrosclerosis) ο‚— Thickened basement membrane in glomerulus ο‚— Causes microalbuminuria (300 mg / day) ο‚— Nodular scarring and destruction of glomerulus. ο‚— Kimmelstiel - Wilson lesion. Pathognomonic for diabetes mellitus.
  • 62. ο‚— Retinopathy ο‚— Leading cause of blindness. DM has increased risk for cataracts and glaucoma ο‚— Pathogenesis: ο‚— new vessels, fragile vessels, microaneurysms, hemorrhage. Followed by scarring and retinal detachment. Takes 20 years to develop. 100% of Type 1; 60% Type 2. Need to evaluate yearly. Retinal photos excellent.
  • 63. ο‚— Foot ulcers ο‚— Most common reason for hospitalization ο‚— Due to impaired circulation (PVD) ο‚— Abnormal glycoprotein thickens vessel wall ο‚— Chronic hypoxia (glycohgb has > affinity for O2) ο‚— Due to neuropathy ο‚— Cannot feel pain to prevent injury ο‚— Prevention: Wear good closed-toe shoes, white cotton socks, keep feet clean and dry, clip toenails straight across, inspect feet daily.
  • 64. ο‚— Infections ο‚— Skin: boils and abscesses ο‚— Urinary tract infections - quickly spread to kidneys ο‚— Osteomyelitis ο‚— Infected cuts of extremities ο‚— Peridontal disease ο‚— Finger and toenail fungus

Editor's Notes

  1. Hyperglycemia in type 2 diabetics can be viewed as a continuum of progressive insulin resistance; this pathophysiology underscores the gradual development of increasing insulin resistance (first in muscle cells then in liver cells) with resultant hyperinsulinemia and culminating in beta cell failure and decreasing insulin levels. The stages in Diabetes can be characterized as follows: Stage 1: Normal glucose tolerance; some degree of hyperinsulinism but no evidence of impaired glucose tolerance (HgA1c under 5.5)Stage 2: Impaired glucose tolerance develops when muscles have significant insulin resistance and the raised insulin levels are not enough to bring the glucose to normal after a meal. Since the liver is more sensitive to insulin than muscle, fasting hyperglycemia has not developed (HgA1c= 5.5-6.1).Stage 3: Both muscle and liver demonstrate insulin resistance; the hyperinsulinemia does not prevent the liver from generating glucose in the fasting state and this is reflected in an elevated fasting glucose level (HgA1c = 6.2-7.5).Stage 4: The pancreas is now failing and the insulin levels start to falter. There is both moderately severe fasting hyperglycemia as the liver increases its glucose output as well as poorly controlled Diabetes (HgA1c = 7.6 - 10).Stage 5: The pancreas has overtly failed. The patient has severe fasting as well as severe insulin resistance; oral agents on their own will not correct this hyperglycemia (HgA1c is more than 10).Understanding these stages is important in managing diabetics more effectively. Thus, in a patient who is in stage 4, providing monotherapy is unlikely to work effectively. In such cases, both an insulin secretagogue (to stimulate insulin secretion) as well as an insulin sensitizer (to minimize insulin resistance) is needed to meet the moderately severe hyperglycemia that develops.Approved oral diabetic agents by mechanism of action include: Insulin secretagogues: Sulfonylureas and meglitinidesInsulin sensitizers: Metformin and thiazolidinediones
  2. Centralpontinemyelinolysis is a neurologic disease caused by severe damage of the myelin sheath of nerve cells in the brainstem, more precisely in the area termed the pons. It can also occur outside the pons. [1] The term \"osmotic demyelinization syndrome\" is similar to \"centralpontinemyelinolysis\", but also includes areas outside the pons. [2]